| |
|
|
|
Catabasis Pharmaceuticals Inc.  
|
|
6.02 -0.02 (-0%) |
09-16 12:43 |
|
Open: |
5.91 |
Pre close: |
6.04 |
Target:
|
7.84
|
|
High: |
6.07 |
Low: |
5.87 |
Resistance:
|
6.72
7.30
|
|
Volume: |
3,512 |
Market Cap: |
70M |
Support:
|
5.77
4.80
|
|
|
|
|
|
Technical Analysis |
|
Moving Averages |
MA(5):
|
6.10
 |
MACD |
MACD(12,26):
|
-0.18 |
|
MA(20): |
6.34 |
Signal(12,26,9): |
-0.17 |
|
MA(100): |
6.99 |
Stochastic Oscillator |
%K(14,3):
|
20.73 |
|
MA(250): |
6.63 |
%D(3): |
24.36 |
|
Average Volume(K) |
3-Month: |
4568
|
52-Week |
High:
|
9.76 |
|
10-Days: |
2818 |
Low: |
3.60 |
|
RSI |
RSI(14):
|
41.87 |
Change(%): |
-21.0 |
|
Financials, Statistics and Valuation |
|
EPS |
-2.810 |
Return on Equity (ttm) |
-55.9 |
Shares Out. (M) |
11.62 |
|
EPS Est. Current Year |
-1.390 |
Return on Assets (ttm) |
-31.3 |
Shares Float (M) |
11.00 |
|
EPS Est. Next Year |
-1.100 |
PEG Ratio |
0.00 |
% Held by Insiders |
1.87 |
|
EPS Est. Next Quarter |
-0.330 |
Qtrly Rev. Growth |
0.0 |
% Held by Institutions |
33.18 |
|
Forward EPS |
-1.190 |
Gross Profit (p.s.) |
0.000 |
Shares Short (K) |
613 |
|
Book Value (p.s.) |
3.750 |
EBITDA (p.s.) |
-2.137 |
P/E |
-2.14 |
|
Sales Per Share |
0.000 |
Qtrly Earnings Growth |
0.00 |
P/BV |
1.60 |
|
Profit Margin |
0.00 |
Operating Cash Flow
(M) |
-23.37 |
P/S |
0.00 |
|
Operating Margin |
0.00 |
Levered Free Cash Flow
(M) |
-14.17 |
P/CF |
-2.99 |
|
|
|
|
|
|
